tiprankstipranks
Trending News
More News >
Bwx Technologies Inc (BWXT)
:BWXT

BWX Technologies (BWXT) AI Stock Analysis

Compare
899 Followers

Top Page

BW

BWX Technologies

(NYSE:BWXT)

78Outperform
BWX Technologies demonstrates a strong financial performance with robust revenue growth and strategic investments driving future potential. While technical indicators suggest a cautious short-term outlook, the positive earnings call underscores a promising long-term trajectory. The valuation appears high, which might limit upside potential, but the company's strategic positioning and growth prospects in the Aerospace & Defense sector remain compelling.
Positive Factors
Acquisition Impact
The acquisitions of A.O.T and Kinetrics aim to unlock further growth opportunities and enhance BWXT's special materials and nuclear medicine portfolios.
Growth Opportunities
Growth potential in its commercial division--in both power applications and medical radioisotopes--shows it is not a one-trick pony.
Strategic Positioning
BWXT's government division has a monopoly on U.S. Navy nuclear reactors and the fuel that drives them.
Negative Factors
Dividend Forecast
Due to BWXT's recent acquisition activity, the 2025 dividend increase forecast has been removed and share repurchase estimates decreased.
Financial Adjustments
BWXT's quantified 2025 EPS guidance to a range of $3.40–$3.55, up 1.8%-6.3% year-over-year, bracketing consensus but above prior 2025 EPS forecast.
Market Competition
BWXT ended 4Q24 with a backlog of $4,842.5M, up 21.1% year-over-year and 43.2% quarter-over-quarter, above forecast.

BWX Technologies (BWXT) vs. S&P 500 (SPY)

BWX Technologies Business Overview & Revenue Model

Company DescriptionBWX Technologies, Inc. manufactures and sells nuclear components in the United States, Canada, and internationally. It operates in three segments: Nuclear Operations Group, Nuclear Power Group, and Nuclear Services Group. The Nuclear Operations Group segment provides precision naval and critical nuclear components, reactors, nuclear fuel, and assemblies for the United States Department of Energy/National Nuclear Security Administration's Naval Nuclear Propulsion Program and other uses; missile launch tubes for United States Navy submarines; close-tolerance and equipment for nuclear applications; and converts Cold War-era government stockpiles of high-enriched uranium, as well as receives, stores, characterizes, dissolves, recovers, and purifies uranium-bearing materials; supplies research reactor fuel elements for colleges, universities, and national laboratories; and components for defense applications. The Nuclear Power Group segment offers commercial nuclear steam generators, nuclear fuel, fuel handling systems, pressure vessels, reactor components, heat exchangers, tooling delivery systems, and containers; engineering and in-plant services for nuclear power plants; designs, manufactures, commissions, and services nuclear power generation equipment; in-plant inspection, maintenance, and modification services, as well as non-destructive examination and tooling/repair solutions; and supplies medical radioisotopes and radiopharmaceuticals for research, diagnostic, and therapeutic uses. The Nuclear Services Group segment provides nuclear materials processing, environmental site restoration, and management and operating services; develops technology for nuclear power sources application; and designs, engineers, licenses, and manufactures nuclear reactors. The company was formerly known as The Babcock & Wilcox Company and changed its name to BWX Technologies, Inc. in June 2015. BWX Technologies, Inc. was founded in 1867 and is headquartered in Lynchburg, Virginia.
How the Company Makes MoneyBWXT generates revenue through multiple streams. A significant portion of its income comes from government contracts, particularly with the U.S. Department of Defense and the Department of Energy. These contracts involve the supply of nuclear components and services, including the production of naval nuclear reactors and nuclear fuel. BWXT also earns revenue from its commercial nuclear services, which include the design and supply of nuclear power generation systems and components to various clients. Additionally, the company engages in nuclear materials management and environmental site restoration, further diversifying its income sources. Strategic partnerships and long-term contracts with government entities are critical factors contributing to BWXT's financial performance.

BWX Technologies Financial Statement Overview

Summary
BWX Technologies presents a solid financial outlook with strong revenue growth and stable profitability margins. The company's balance sheet is healthy, marked by consistent equity growth and manageable debt levels. Cash flow from operations is robust, supporting capital investments and enhancing financial flexibility. Overall, BWXT is well-positioned within the Aerospace & Defense sector, though attention should be paid to debt trends and capital expenditures.
Income Statement
85
Very Positive
BWX Technologies shows a strong revenue growth trend from 2019 to 2024, with a significant boost in gross profit margin from 2019 to 2024. Key profitability margins, such as EBIT and EBITDA, remain robust, indicating efficient operations. However, a slight dip in net profit margin from 2021 is noted.
Balance Sheet
75
Positive
The company's balance sheet reflects a solid equity position with consistent growth in stockholders' equity. The debt-to-equity ratio shows moderate leverage, which is typical for the industry, but the increasing trend in total debt warrants monitoring. The equity ratio indicates a stable asset base supported by equity.
Cash Flow
80
Positive
BWX Technologies demonstrates strong operating cash flows with substantial growth in free cash flow over recent years. The free cash flow to net income ratio indicates efficient conversion of income into cash, although capital expenditures remain high, impacting net cash flow.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
2.70B2.50B2.23B2.12B2.12B
Gross Profit
655.21M620.59M551.93M550.28M575.40M
EBIT
380.61M383.06M348.57M345.85M358.55M
EBITDA
474.06M447.00M386.01M470.85M422.34M
Net Income Common Stockholders
281.94M245.85M238.19M305.87M278.67M
Balance SheetCash, Cash Equivalents and Short-Term Investments
74.11M78.62M39.05M37.70M46.32M
Total Assets
2.87B2.75B2.62B2.50B2.29B
Total Debt
1.06B1.23B1.29B1.19B951.42M
Net Debt
981.36M1.15B1.25B1.16B908.82M
Total Liabilities
1.79B1.81B1.87B1.86B1.68B
Stockholders Equity
1.08B933.35M748.31M637.17M617.77M
Cash FlowFree Cash Flow
254.78M212.41M46.39M74.97M-58.59M
Operating Cash Flow
408.43M363.70M244.70M386.03M196.44M
Investing Cash Flow
-154.56M-155.64M-256.24M-304.65M-265.32M
Financing Cash Flow
-252.78M-169.37M13.95M-90.14M25.05M

BWX Technologies Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price102.31
Price Trends
50DMA
101.70
Positive
100DMA
110.18
Negative
200DMA
109.13
Negative
Market Momentum
MACD
0.29
Negative
RSI
51.97
Neutral
STOCH
77.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BWXT, the sentiment is Neutral. The current price of 102.31 is above the 20-day moving average (MA) of 100.16, above the 50-day MA of 101.70, and below the 200-day MA of 109.13, indicating a neutral trend. The MACD of 0.29 indicates Negative momentum. The RSI at 51.97 is Neutral, neither overbought nor oversold. The STOCH value of 77.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for BWXT.

BWX Technologies Risk Analysis

BWX Technologies disclosed 29 risk factors in its most recent earnings report. BWX Technologies reported the most risks in the “Production” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

BWX Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$9.35B33.3328.00%0.96%8.31%14.74%
HIHII
77
Outperform
$8.55B15.6112.56%2.43%0.71%-18.39%
DRDRS
76
Outperform
$9.21B43.508.73%0.25%14.44%26.36%
63
Neutral
$8.32B779.62
14.77%
62
Neutral
$4.16B11.315.46%215.65%4.12%-8.47%
AIAIR
61
Neutral
$1.84B246.75-1.08%21.07%-120.95%
59
Neutral
$4.89B299.441.40%9.57%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BWXT
BWX Technologies
102.31
9.51
10.25%
AIR
AAR
50.91
-16.88
-24.90%
HII
Huntington Ingalls
217.22
-50.64
-18.91%
KTOS
Kratos Defense
32.12
14.28
80.04%
DRS
Leonardo Drs
35.14
13.89
65.36%
SARO
StandardAero, Inc.
24.87
-8.10
-24.57%

BWX Technologies Earnings Call Summary

Earnings Call Date: Feb 24, 2025 | % Change Since: 2.68% | Next Earnings Date: May 5, 2025
Earnings Call Sentiment Positive
BWXT reported strong financial results for 2024, with significant growth in revenue and backlog. Strategic investments and acquisitions are expected to drive future growth. However, there are challenges in government operations margins and foreign currency headwinds impacting commercial operations. Overall, the highlights significantly outweigh the lowlights, indicating a positive outlook.
Highlights
Record Financial Performance
BWXT reported record revenue, adjusted EBITDA, adjusted earnings per share, and free cash flow for 2024, all meeting or exceeding full-year guidance metrics.
Backlog Growth
The company ended 2024 with a backlog of $4.8 billion, up 21% year-over-year due to large contract awards in both operating segments.
Strategic Investments and Acquisitions
Completed the acquisition of A.O.T., expanding the special materials business line, and announced an agreement to acquire Kinectrics Inc., expected to close in mid-2025.
Commercial Operations Growth
Commercial power revenue grew by more than 10% in 2024, with a record backlog of $930 million, up 19%, supporting expectations for another year of double-digit growth.
Medical Revenue Surge
BWXT Medical's revenue grew 23% in 2024, with EBITDA turning more meaningfully positive, driven by CDMO and PET diagnostics business lines.
Lowlights
Government Operations Margin Pressure
Government operations faced a decline in adjusted EBITDA margin due to shifting mix toward less mature programs and higher labor costs.
Corporate Expense Timing
Higher corporate EBITDA expense in Q4 due to timing of healthcare and other expenses, impacting quarterly results.
Foreign Currency Headwinds
Commercial operations guidance includes a foreign currency translation headwind of approximately 5% due to the strength of the U.S. dollar versus the Canadian dollar.
Company Guidance
During BWX Technologies' fourth quarter and full year 2024 earnings conference call, the company reported record financial performance, achieving or surpassing its full-year guidance metrics. Key highlights included a 6% growth in adjusted EBITDA, a 10% rise in adjusted earnings per share, and a nearly 20% increase in free cash flow. The company ended 2024 with a backlog of $4.8 billion, marking a 21% year-over-year increase, mainly due to large contract awards in its operating segments. Looking forward to 2025, BWXT anticipates revenue of approximately $3 billion, with mid-single digit growth in government operations and significant growth in commercial operations, including contributions from acquisitions. The guidance also includes adjusted EBITDA between $550 million and $570 million and non-GAAP EPS of $3.40 to $3.55. The company's strategic investments, such as the expansion of the BWXT Innovation Campus and the acquisition of A.O.T., aim to enhance capabilities and sustain growth.

BWX Technologies Corporate Events

Executive/Board Changes
BWX Technologies Grants PSUs to Executive Vice President
Neutral
Jan 10, 2025

BWX Technologies has granted 10,000 performance restricted stock units (PSUs) to Robb A. LeMasters, Executive Vice President and CFO, valued at $1.15 million. The PSUs aim to incentivize long-term shareholder value and will vest based on achieving financial metrics and acquisition targets by the end of 2027.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.